rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Jennifer K. Moses

Director

Company insider

Files Form 4 as: Director, Viridian Therapeutics; CFO, G1 Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
75
Buys
0
Sells
15
Bought
$0
Sold
$378K
Companies
2
Companies where not an officer
1
First trade
2 Jan 2018
Last trade
1 Jul 2026
Last filed
2 Jul 2026

Companies traded

Where they are an officer
G1 TherapeuticsOfficer · last 5 Jan 20230 buys · 15 sells
Everywhere else they filed: board seats, 10% stakes, other companies
VRDN Viridian TherapeuticsDirector · Biotechnology · last 1 Jul 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
1 Jul 2026filed 2 Jul 2026VRDN Viridian Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—32,341 at $0.00filing
1 Jul 2026filed 2 Jul 2026VRDN Viridian Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—32,341 at $0.00filing
1 Jul 2025filed 2 Jul 2025VRDN Viridian Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—21,000 at $0.00filing
26 Jun 2024filed 28 Jun 2024VRDN Viridian Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—21,000 at $0.00filing
14 Jun 2023filed 16 Jun 2023VRDN Viridian Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
5 Jan 2023filed 5 Jan 2023G1 TherapeuticsSEC FORM 4 Sold$3,944729 at $5.41filing
4 Jan 2023filed 5 Jan 2023G1 TherapeuticsSEC FORM 4 Sold$9,1461,639 at $5.58filing
3 Jan 2023filed 5 Jan 2023G1 Therapeuticsoption or derivativeSEC FORM 4 Code A—44,600 at $0.00filing
3 Jan 2023filed 5 Jan 2023G1 TherapeuticsSEC FORM 4 Code A—22,300 at $0.00filing
8 Jun 2022filed 10 Jun 2022VRDN Viridian Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—12,500 at $0.00filing
1 Feb 2022filed 2 Feb 2022G1 Therapeuticsoption or derivativeSEC FORM 4 Code M—2,000 at $0.00filing
1 Feb 2022filed 2 Feb 2022G1 Therapeuticsoption or derivativeSEC FORM 4 Code M—333 at $0.00filing
1 Feb 2022filed 2 Feb 2022G1 TherapeuticsSEC FORM 4 Code M$1,239333 at $3.72filing
1 Feb 2022filed 2 Feb 2022G1 TherapeuticsSEC FORM 4 Code M$8,3402,000 at $4.17filing
5 Jan 2022filed 5 Jan 2022G1 TherapeuticsSEC FORM 4 Sold$15K1,445 at $10.61filing
3 Jan 2022filed 5 Jan 2022G1 Therapeuticsoption or derivativeSEC FORM 4 Code A—53,000 at $0.00filing
3 Jan 2022filed 5 Jan 2022G1 TherapeuticsSEC FORM 4 Code A—12,000 at $0.00filing
14 Jul 2021filed 15 Jul 2021VRDN Viridian Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
3 Mar 2021filed 4 Mar 2021G1 Therapeuticsoption or derivativeSEC FORM 4 Code M—3,000 at $0.00filing
3 Mar 2021filed 4 Mar 2021G1 TherapeuticsSEC FORM 4 Code M$11K3,000 at $3.72filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed15

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.